1. Tumor-agnostic precision oncology: striving to prioritize internationalization for the management of cancer patients

   • Yuko Kitagawa

   Editorial 05 May 2020 Pages: 995 - 996

2. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System

   • Hiromi Onizuka
   • Kenta Masui
   • Takashi Komori

   Invited Review Article 28 May 2020 Pages: 997 - 1003

   

3. Clinical impact of revisions to the WHO classification of diffuse gliomas and associated future problems

   • Yukihiko Sonoda

   Invited Review Article 04 February 2020 Pages: 1004 - 1009

4. Management of gastrointestinal perforation related to radiation

   • Yawen Zheng
   • Wei Gao
   • Ligang Xing

   Review Article 18 April 2020 Pages: 1010 - 1015

   

5. Salivary metabolites to detect patients with cancer: a systematic review

   • Daniele Xavier Assad
   • Elisa Cançado Porto Mascarenhas
   • Eliete Neves Silva Guerra

   Review Article 27 March 2020 Pages: 1016 - 1036

   

6. Efficacy of neoadjuvant and adjuvant chemotherapy for localized and locally advanced upper tract urothelial carcinoma: a systematic review and meta-analysis

   • Fahad Quhal
   • Keiichiro Mori
   • Shahrokh F. Shariat

   Review Article 23 March 2020 Pages: 1037 - 1054

   

7. Calpain suppresses cell growth and invasion of glioblastoma multiforme by producing the cleavage of filamin A

   • Lin Cai
   • Qun Li
   • Xianghe Lu

   Original Article 27 February 2020 Pages: 1055 - 1066

   

8. Extent of neck dissection for patients with clinical N1 oral cancer

   • Yasumasa Kakei
   • Hirokazu Komatsu
   • Masaya Akashi

   Original Article Open access 05 March 2020 Pages: 1067 - 1071

9. Down-regulation of miR-200c associates with poor prognosis of oral squamous cell carcinoma

   • Jian Song
   • Nian Zhang
   • Zhuang Zhang

   Original Article 11 March 2020 Pages: 1072 - 1078

   

10. Use of a prognostic risk score that aggregates the FDG-PET/CT SUVmax, tumor size, and histologic group for predicting the prognosis of pStage I lung adenocarcinoma

    • Naoya Kawakita
    • Hiroaki Toba
    • Akira Tangoku

    Original Article 04 March 2020 Pages: 1079 - 1089

    

11. A phase I study of docetaxel/oxaliplatin/S-1 (DOS) combination neoadjuvant chemotherapy for patients with locally advanced adenocarcinoma of the esophagogastric junction

    • Kei Hosoda
    • Mizutomo Azuma
    • Naoki Hiki

    Original Article 02 March 2020 Pages: 1090 - 1097

12. Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer

    • Yukihiro Nakatani
    • Ken Kato
    • Narikazu Boku

    Original Article 18 March 2020 Pages: 1098 - 1104

    

13. SAMD14 promoter methylation is strongly associated with gene expression and poor prognosis in gastric cancer

    • Xiaoyang Xu
    • Xiaojing Chang
    • Dongqiu Dai

    Original Article 21 March 2020 Pages: 1105 - 1114

    

14. Efficacy and feasibility of S-1 plus oxaliplatin (C-SOX) for treating patients with stage III colon cancer (KSCC1303): final analysis of 3-year disease-free survival

    • Koji Ando
    • Yasunori Emi
    • Kyushu Study Group of Clinical Cancer (KSCC)

    Original Article 18 March 2020 Pages: 1115 - 1122

    

15. Prophylactic efficacy of ninjin’yoeito for oxaliplatin-induced cumulative peripheral neuropathy in patients with colorectal cancer receiving postoperative adjuvant chemotherapy: a randomized, open-label, phase 2 trial (HOPE-2)

    • Yoshiharu Motoo
    • Yasuto Tomita
    • Hideto Fujita

    Original Article 30 March 2020 Pages: 1123 - 1129

    

16. Variations in clinical features and oncologic behaviors of T1 colorectal cancer according to tumor location

    • Akira Ouchi
    • Kazuhiro Toriyama
    • Koji Komori

    Original Article 02 March 2020 Pages: 1130 - 1136

17. Prognostic significance of β2-adrenergic receptor expression in patients with surgically resected colorectal cancer

    • Hiroomi Ogawa
    • Kyoichi Kaira
    • Ken Shirabe

    Original Article 17 March 2020 Pages: 1137 - 1144

    

18. RETRACTED ARTICLE: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma

    • Chuantao Zhang
    • Jianxiang Liu
    • Yufeng Xing

    Original Article 02 April 2020 Pages: 1145 - 1154

    

19. Clinical outcomes of repeat partial nephrectomy compared to initial partial nephrectomy of a solitary kidney

    • Kazuhiko Yoshida
    • Tsunenori Kondo
    • Kazunari Tanabe

    Original Article 17 February 2020 Pages: 1155 - 1162

    

20. Risk for intravesical recurrence of bladder cancer stratified by the results on two consecutive UroVysion fluorescence in situ hybridization tests: a prospective follow-up study in Japan

    • Atsushi Ikeda
    • Takahiro Kojima
    • Hiroyuki Nishiyama

    Original Article Open access 03 March 2020 Pages: 1163 - 1169

    

21. Impact of a reduction in follow-up frequency on life expectancy in uterine cervical cancer patients

    • Yuri Matsumoto
    • Seiji Mabuchi
    • Tadashi Kimura

    Original Article 09 March 2020 Pages: 1170 - 1177

    

22. Evaluation of a routine second curettage for hydatidiform mole: a cohort study

    • Eiko Yamamoto
    • Kimihiro Nishino
    • Fumitaka Kikkawa

    Original Article 06 March 2020 Pages: 1178 - 1186

    

23. Fertility preservation and fulfillment of parenthood after treatment of hematological malignancies: results from the ‘Aftercare in Blood Cancer Survivors’ (ABC) study

    • Christine Schmitz
    • Julia Baum
    • Ulrich Dührsen

    Original Article Open access 05 March 2020 Pages: 1187 - 1194

    

24. The efficacy and safety of Apatinib mesylate in the treatment of metastatic osteosarcoma patients who progressed after standard therapy and the VEGFR2 gene polymorphism analysis

    • Jia-Yong Liu
    • Bao-Rang Zhu
    • Xin Sun

    Original Article 25 March 2020 Pages: 1195 - 1205